|
ACTR10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.02079489095308E-11 |
| Normal-vs-Stage2 |
2.37640000011474E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.221600E-01 |
| Stage1-vs-Stage3 |
1.63936999999503E-05 |
| Stage1-vs-Stage4 |
2.92790000000487E-06 |
| Stage2-vs-Stage3 |
5.512100E-02 |
| Stage2-vs-Stage4 |
3.490200E-02 |
| Stage3-vs-Stage4 |
8.078600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.62719999696748E-08 |
| Normal-vs-Asian |
1.903600E-03 |
| Caucasian-vs-AfricanAmerican |
3.923400E-01 |
| Caucasian-vs-Asian |
8.792800E-01 |
| AfricanAmerican-vs-Asian |
8.446200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.03660421860263E-11 |
| Male-vs-Female |
2.646100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.15460005392742E-09 |
| Normal-vs-Age(41-60Yrs) |
8.69304628281498E-14 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
3.54949999947785E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.206200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.487800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.790800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.158800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.284400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.481000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.384240E-01 |
| Normal-vs-Grade 2 |
1.30130000108863E-08 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
5.351900E-02 |
| Grade 1-vs-Grade 3 |
6.777000E-04 |
| Grade 1-vs-Grade 4 |
2.03560000000547E-06 |
| Grade 2-vs-Grade 3 |
9.92149999934355E-08 |
| Grade 2-vs-Grade 4 |
1.14059983680193E-10 |
| Grade 3-vs-Grade 4 |
1.298040E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.90990000037417E-07 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.35199962336685E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63480340376054E-12 |
| Normal-vs-N1 |
1.63535851527286E-12 |
| N0-vs-N1 |
4.32989999999966E-05 |
|
|
